Sun Yanli, Sun Yanhua, Zhao Ronglan
Institute of Nanomedicine Technology, Department of Laboratory Medicine, Institutional Key Laboratory of Clinical Laboratory Diagnostics, 12th 5-Year Project of Shandong Province, Key Discipline of Clinical Laboratory Medicine of Shandong Province, Affiliated Hospital of Weifang Medical University, Weifang Medical University, Weifang 261053, China.
Department of Hematology, Weifang People's Hospital, Weifang 261000, China.
J Biosci Bioeng. 2017 Aug;124(2):242-249. doi: 10.1016/j.jbiosc.2017.03.012. Epub 2017 Apr 22.
MicroRNAs have great therapeutic potential in cancer and other diseases. However, their instability and low in vivo delivery efficiency limits their application. Recombinant PP7 bacteriophage-based virus-like particles (VLPs) could protect microRNAs against rapid degradation by RNase by packaging specific exogenous pre-microRNAs using the pac site. Insertion of a cell-penetrating peptide (CPP) into the AB-loop of VLPs could significantly improve the delivery efficiency of microRNAs into mammalian cells. Unlike other microRNA delivery methods (viral or non-viral vectors), recombinant PP7 VLPs carrying a CPP and microRNA could be efficiently expressed in Escherichia coli using the one-plasmid double expression system. Here we showed that PP7 VLPs carrying a CPP penetrated hepatoma SK-HEP-1 cells and delivered the pre-microRNA-23b, which was processed into a mature product within 24 h; a concentration of 10 nM was sufficient for the inhibition of hepatoma cell migration via the downregulation of liver-intestine cadherin expression. Furthermore, PP7 VLPs carrying a CPP and a pre-microRNA were not infectious, replicative, or cytotoxic. Therefore, recombinant PP7 VLPs can be used for simultaneous and targeted delivery of both microRNAs and peptides because of their ability to package specific exogenous RNA using the pac site and to display peptides.
微小RNA在癌症和其他疾病中具有巨大的治疗潜力。然而,它们的不稳定性和体内递送效率低限制了其应用。基于重组PP7噬菌体的病毒样颗粒(VLP)可以通过使用pac位点包装特定的外源前体微小RNA来保护微小RNA免受核糖核酸酶的快速降解。将细胞穿透肽(CPP)插入VLP的AB环中可以显著提高微小RNA向哺乳动物细胞的递送效率。与其他微小RNA递送方法(病毒或非病毒载体)不同,携带CPP和微小RNA的重组PP7 VLP可以使用单质粒双表达系统在大肠杆菌中高效表达。在这里,我们表明携带CPP的PP7 VLP穿透肝癌SK-HEP-1细胞并递送前体微小RNA-23b,其在24小时内被加工成成熟产物;10 nM的浓度足以通过下调肝肠钙黏蛋白的表达来抑制肝癌细胞迁移。此外,携带CPP和前体微小RNA的PP7 VLP没有传染性、复制性或细胞毒性。因此,重组PP7 VLP因其能够使用pac位点包装特定的外源RNA并展示肽段,可用于同时靶向递送微小RNA和肽段。